Tissue factor (TF) and tissue factor pathway inhibitor (TFPI) in amniotic fluid and blood plasma: implications for the mechanism of amniotic fluid embolism

By Uszynski M.   Zekanowska E.   Uszynski W.   Kuczynski J.  

European Journal of Obstetrics and Gynecology and Reproductive Biology, Vol. 95, Iss. 2, 2001-04 ,pp. : 163-166

Elsevier

Access to resources Recommend Favorite

Amniotic fluid prostaglandin F2 increases even in sterile amniotic fluid and is an independent predictor of impending delivery in preterm premature rupture of membranes

By Lee Si Eun   Park In-Sook   Romero Roberto   Yoon Bo Hyun  

Journal of Maternal-Fetal and Neonatal Medicine, Vol. 22, Iss. 10, 2009-10 ,pp. : 880-886

Informa Healthcare

Access to resources Recommend Favorite

Effect of amniotic fluid upon prostaglandin E 2 and I 2 production by cultured human myometrial cells

By Kayem G.   Dallot E.   Ferre F.   Cabrol D.  

European Journal of Obstetrics and Gynecology and Reproductive Biology, Vol. 108, Iss. 2, 2003-06 ,pp. : 152-156

Elsevier

Access to resources Recommend Favorite

Inhibition of prostaglandin E 2 production in myometrial and amniotic cells in culture by human amniotic fluid. Loss of inhibition after intra-uterine fetal death

By Cabrol D.   Carbonne B.   Dallot E.   Josserand S.   Cavaille F.   Ferre F.  

European Journal of Obstetrics and Gynecology and Reproductive Biology, Vol. 64, Iss. 1, 1996-01 ,pp. : 135-140

Elsevier

Access to resources Recommend Favorite

Human β-defensin-2: A natural antimicrobial peptide present in amniotic fluid participates in the host response to microbial invasion of the amniotic cavity

By Soto Eleazar   Espinoza Jimmy   Nien Jyh Kae   Kusanovic Juan Pedro   Erez Offer   Richani Karina   Santolaya-Forgas Joaquin   Romero Roberto  

Journal of Maternal-Fetal and Neonatal Medicine, Vol. 20, Iss. 1, 2007-01 ,pp. : 15-22

Informa Healthcare

Access to resources Recommend Favorite